Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol and Older Adult Cannabis Users
NCT06290063Phase 2Recruiting
- Sponsor
- University of Colorado Boulder
- Start
- May 2024
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in pain, anxiety disorder, major depressive disorder (MDD), sleep disorder, sponsored by University of Colorado Boulder. Started May 2024; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
painanxiety disordermajor depressive disorder (MDD)sleep disorder
Beyond the preview
Go deeper on NCT06290063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06290063.